Article Text

Download PDFPDF
PWE-105 Long term survival of cirrhotics following icu admission – a subgroup of patients with 'resilient' cirrhosis
  1. J Lloyd-Evans1,
  2. T Pembroke2,
  3. A Godkin2
  1. 1Department of Anaesthetics and Intensive Care
  2. 2Department of Gastroenterology and Hepatology, University Hospital of Wales, Cardiff, UK


Introduction Patients with cirrhosis who are admitted to the ICU are considered to have a poor prognosis. Previous studies have sought to identify markers of high predictive value in patients who will not survive their critical care stay. These studies have focused upon early prognosis, rather than longer term survival. We sought to validate previously described outcome predictors and review long-term survival in a cohort of cirrhotic patients admitted to ICU.

Method We performed a retrospective analysis of cirrhotic patients admitted to adult ICU, University Hosptial of Wales (Cardiff, UK) between 2009–14. Admission information was collated from the Intensive Care National Audit and Research Centre database. Child-Pugh, Model for End-stage Liver Disease-Na (MELD-Na) and Acute Physiology and Chronic Health Evaluation (APACHE II) scores were derived from data on admission to critical care. Statisical analyses were conducted with SPSS.

Results One hundred and fifty one cirrhotics (2.8% of all critical care admissions) were admitted to the ICU with a mean age of 54 (range 22–80) and a male preponderance (65.6%). The predominant aetiology was alcoholic liver disease (ALD, 107/151, 70.9%). The reasons for ICU admission were variceal bleed 29.8%; sepsis 25.2%; decompensation 13.9%;non variceal bleed 5.3% and other 26%. ICU mortality was 43.7% for the 151 patients. Mean follow up after ICU discharge was 788 days (range 26–1722).

Hyponatraemia (p < 0.001), coagulopathy (p = 0.02), APACHE II (p = 0.004) and MELD-Na scores (p < 0.0001) were significantly associated with mortality. Patients diagnosed as decompensation with no obvious underlining precipitant had a worse prognosis than those with precipitants (e.g. variceal bleeding, sepsis) which was maintained at follow up (p = 0.05). Child’s A, B and C stage patients had a mean overall survival of 1274, 976 and 690 days respectively (p = 0.01).

Seventy-eight patients were discharge from hospital. Only 6 of these patients died, all with Child’s B liver disease. Only attending outpatient follow up clinic was associated with increased survival (p = 0.01 1373 v 1668 days).

Conclusion Nearly half of all cirrhotics admitted to the ICU die before discharge, and two thirds of all patients have alcohol as an aetiological factor, emphasising the burden on our society. As expected, commonly used scoring systems predict short-term outcome, but often do not reflect long-term survival.

Cirrhotics who survive the challenge of ICU admission seem to have quite marked physiological resilience and capacity for recovery with a good long term prognosis. Interestingly only patients with Child’s B cirrhosis continued to demonstrate a post-hospital discharge mortality, warranting further investigation for underlying reasons.

Disclosure of interest None Declared.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.